Difference between revisions of "Part:BBa K2008005"
Line 3: | Line 3: | ||
<partinfo>BBa_K2008005 short</partinfo> | <partinfo>BBa_K2008005 short</partinfo> | ||
− | This part contains an active nonamer from the Bowman Birk Protease Inhibitor (BBI) with the addition of lysine, serine, cysteine, and isoleucine (KSCI) tag on the N-terminal end and a phenylalanine (F) tag on the C-terminal end to increase BBI solubility. A B. subtilis secretory signal peptide sequence is included to allow for secretion of the peptide directly into surrounding media. A transdermal tag | + | This part contains an active nonamer from the Bowman Birk Protease Inhibitor (BBI) with the addition of lysine, serine, cysteine, and isoleucine (KSCI) tag on the N-terminal end and a phenylalanine (F) tag on the C-terminal end to increase BBI solubility. A <i>B. subtilis</i> secretory signal peptide sequence is included to allow for secretion of the peptide directly into surrounding media. A transdermal tag, TD1, (https://parts.igem.org/Part:BBa_K1074000) is fused to the N-terminus of BBI to allow for diffusion of the peptide across the skin.<br><br> |
− | + | This coding sequence is under the control of the constitutive <i>B. subtilis</i> promoter pVeg (https://parts.igem.org/Part:BBa_K143012) and a strong <i>B. subtilis</i> RBS (https://parts.igem.org/Part:BBa_K780001).<br><br> | |
− | This coding sequence is under the control of the constitutive B. subtilis promoter pVeg (BBa_K143012) and a strong B. subtilis RBS (BBa_K780001). | + | |
− | + | ||
− | + | ||
Note: This part is a composite part, not a basic part, but it could not be added as composite at the time of entry. | Note: This part is a composite part, not a basic part, but it could not be added as composite at the time of entry. | ||
Revision as of 19:23, 18 October 2016
pVeg->sec-TD1-KSCI-BBI
This part contains an active nonamer from the Bowman Birk Protease Inhibitor (BBI) with the addition of lysine, serine, cysteine, and isoleucine (KSCI) tag on the N-terminal end and a phenylalanine (F) tag on the C-terminal end to increase BBI solubility. A B. subtilis secretory signal peptide sequence is included to allow for secretion of the peptide directly into surrounding media. A transdermal tag, TD1, (https://parts.igem.org/Part:BBa_K1074000) is fused to the N-terminus of BBI to allow for diffusion of the peptide across the skin.
This coding sequence is under the control of the constitutive B. subtilis promoter pVeg (https://parts.igem.org/Part:BBa_K143012) and a strong B. subtilis RBS (https://parts.igem.org/Part:BBa_K780001).
Note: This part is a composite part, not a basic part, but it could not be added as composite at the time of entry.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]